Renal Division, Shanxi Medical University Second Hospital, Taiyuan, Shanxi, China.
PLoS One. 2018 Nov 7;13(11):e0206134. doi: 10.1371/journal.pone.0206134. eCollection 2018.
Dietary protein restriction has long been thought to play an important role in the progression of chronic kidney disease (CKD); however, the effect of dietary protein on the rate of decline in kidney function remains controversial.
We undertook a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the influence of protein restriction on chronic kidney disease.
Ovid MEDLINE (from 1946 to March 5, 2016), EMBASE (from 1966 to March 5, 2016), and the Cochrane Library (Inception to March 5, 2016) were searched to identify RCTs comparing different levels of protein intake for at least 24 weeks in adult patients with CKD. The outcomes included kidney failure events, the rate of change in estimated glomerular filtration rate (eGFR) per year, all cause death events, and changes in proteinuria, serum phosphorus concentration, serum albumin, and body mass index (BMI).
Nineteen trials with 2492 subjects were analyzed. A low protein diet reduced the risk of kidney failure (odds ratio (OR) = 0.59, 95% CI: 0.41 to 0.85) and end-stage renal disease (ESRD) (OR = 0.64, 95% CI: 0.43 to 0.96), but did not produce a clear beneficial effect for all cause death events (OR = 1.17, 95% CI: 0.67 to 2.06). The change in the mean difference (MD) for the rate of decline in the eGFR was significant (MD: -1.85, P = 0.001), and for proteinuria (MD: -0.44, P = 0.02). A low protein diet also reduced the serum phosphorus concentration (MD: -0.37, 95% CI: -0.5 to -0.24) and BMI (MD: -0.61, 95% CI: -1.05 to -0.17). However the change in albumin presented no significant difference between two groups (MD: 0.23, 95% CI: -0.51 to 0.97).
Based on the findings of our meta-analysis, protein-restricted diet may reduce the rate of decline in renal function and the risk of kidney failure for CKD populations, but did not produce a clear beneficial effect for all cause death events. Besides However, the optimal level of protein intake in different participants is left unanswered, and the nutritional status should be regarded with caution.
长期以来,人们一直认为饮食蛋白质限制在慢性肾脏病(CKD)的进展中起着重要作用;然而,饮食蛋白质对肾功能下降速度的影响仍存在争议。
我们进行了系统评价和荟萃分析,以评估蛋白质限制对慢性肾脏病的影响。
我们在 Ovid MEDLINE(1946 年至 2016 年 3 月 5 日)、EMBASE(1966 年至 2016 年 3 月 5 日)和 Cochrane 图书馆(2016 年 3 月 5 日)中检索了比较成人 CKD 患者至少 24 周不同蛋白质摄入量的随机对照试验(RCT)。主要结局为肾衰竭事件、估算肾小球滤过率(eGFR)每年的变化率、全因死亡事件以及蛋白尿、血磷浓度、血清白蛋白和体重指数(BMI)的变化。
共分析了 19 项涉及 2492 例患者的试验。低蛋白饮食降低了肾衰竭(比值比(OR)=0.59,95%可信区间:0.41 至 0.85)和终末期肾病(ESRD)(OR=0.64,95%可信区间:0.43 至 0.96)的风险,但全因死亡事件(OR=1.17,95%可信区间:0.67 至 2.06)未产生明显的有益效果。eGFR 下降率的平均差异(MD)变化具有统计学意义(MD:-1.85,P=0.001),且对蛋白尿(MD:-0.44,P=0.02)也具有统计学意义。低蛋白饮食还降低了血磷浓度(MD:-0.37,95%可信区间:-0.5 至 -0.24)和 BMI(MD:-0.61,95%可信区间:-1.05 至 -0.17)。然而,两组间白蛋白的变化无统计学差异(MD:0.23,95%可信区间:-0.51 至 0.97)。
基于我们的荟萃分析结果,限制蛋白质的饮食可能会降低 CKD 患者的肾功能下降速度和肾衰竭风险,但对全因死亡事件没有明显的有益效果。然而,对于不同参与者的最佳蛋白质摄入量水平仍未得到解答,应谨慎考虑营养状况。